142 related articles for article (PubMed ID: 2650216)
21. HLA-B, DR matching and cadaver renal allograft survival in New England. New England Organ Bank.
Carpenter CB; Goguen JE; Bradley JW; Turka LA; Cho SI; Milford EL
Transplant Proc; 1989 Feb; 21(1 Pt 1):663-4. PubMed ID: 2650215
[No Abstract] [Full Text] [Related]
22. The impact of HLA-DR incompatibilities on kidney graft function and on the number of rejection treatments. The Dutch Study Group of Renal Transplantation.
Groenewoud AF
Transplant Proc; 1987 Feb; 19(1 Pt 1):683-4. PubMed ID: 3274840
[No Abstract] [Full Text] [Related]
23. Negative cross-match selection of HLA-DR compatible kidneys for highly sensitised patients.
Claas FH
Immunol Lett; 1991 Jul; 29(1-2):61-4. PubMed ID: 1916926
[TBL] [Abstract][Full Text] [Related]
24. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
[TBL] [Abstract][Full Text] [Related]
25. HLA antigen expression and panel reactive antibodies.
Rodriguez L; Caldumbide I; Martinez L; Scagliotti P; Quiroga T
Transplant Proc; 1995 Apr; 27(2):1811-2. PubMed ID: 7725514
[No Abstract] [Full Text] [Related]
26. Beneficial HLA matching: its phase of impact on graft survival.
Gilks WR; Bradley BA; Gore SM
Transplant Proc; 1987 Feb; 19(1 Pt 1):664-5. PubMed ID: 3274833
[No Abstract] [Full Text] [Related]
27. Relationship between HLA compatibility and first liver allograft survival. l'ESPRIT Study Group.
Thorogood J
Transplant Proc; 1993 Aug; 25(4):2655-6. PubMed ID: 8356710
[No Abstract] [Full Text] [Related]
28. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database.
Navarro V; Herrine S; Katopes C; Colombe B; Spain CV
Liver Transpl; 2006 Apr; 12(4):652-8. PubMed ID: 16555339
[TBL] [Abstract][Full Text] [Related]
29. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.
Duquesnoy RJ; Takemoto S; de Lange P; Doxiadis II; Schreuder GM; Persijn GG; Claas FH
Transplantation; 2003 Mar; 75(6):884-9. PubMed ID: 12660519
[TBL] [Abstract][Full Text] [Related]
30. Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team.
Martin S; Connolly J; Jos V
Transplant Proc; 1993 Feb; 25(1 Pt 1):265-6. PubMed ID: 8438295
[No Abstract] [Full Text] [Related]
31. The impact of HLA-A,B match of primary renal allografts subsequent to transplant failure.
Sanfilippo F; Goeken N; Niblack G; Scornik J; Vaughn WK
Transplant Proc; 1987 Feb; 19(1 Pt 1):669-71. PubMed ID: 3274835
[No Abstract] [Full Text] [Related]
32. HLA matching and short/long-term outcome of cadaveric renal allografts: large single-centre data confirm the multicentre analyses.
Petersen P; Schneeberger H; Schleibner S; Illner WD; Hofmann GO; Scholz S; Albert ED; Land W
Transplant Proc; 1995 Feb; 27(1):651-2. PubMed ID: 7879131
[No Abstract] [Full Text] [Related]
33. The impact of special programs for kidney transplantation of highly sensitized patients in Eurotransplant.
Doxiadis II; De Meester J; Smits JM; Witvliet M; de Lange P; Persijn GG; Claas FH
Clin Transpl; 1998; ():115-20. PubMed ID: 10503090
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of an organ-sharing program in providing zero HLA-A,B,DR mismatched kidneys for transplantation in Taiwan.
Lee PC; Lee PH; Shaw CK; Lei HY; Chen JC; Takemoto S
J Formos Med Assoc; 2000 Jun; 99(6):447-52. PubMed ID: 10925549
[TBL] [Abstract][Full Text] [Related]
35. A microabsorption assay to determine acceptable HLA-A and B mismatches for highly immunized patients.
van Eijck EL; van der Keur C; Gijbels Y; Bruning JW; van Rood JJ; Claas FH
Transplant Proc; 1989 Feb; 21(1 Pt 1):724-5. PubMed ID: 2650243
[No Abstract] [Full Text] [Related]
36. Human leukocyte antigens DR and AB and kidney retransplantation.
Thompson JS; Thacker LR; Krishnan G
Transplantation; 2003 Mar; 75(5):718-23. PubMed ID: 12640315
[TBL] [Abstract][Full Text] [Related]
37. Correlation between HLA-DR mismatch and rejection episodes in cardiac transplantation.
Pfeffer PF; Foerster A; Frøysaker T; Thorsby E
Transplant Proc; 1987 Feb; 19(1 Pt 1):691-2. PubMed ID: 3274844
[No Abstract] [Full Text] [Related]
38. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
[TBL] [Abstract][Full Text] [Related]
39. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
[TBL] [Abstract][Full Text] [Related]
40. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
